28.04.2016 Views

Committed to growth

EuroChem-2015-Annual-Report-v2

EuroChem-2015-Annual-Report-v2

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Corporate Governance Report<br />

Maintaining strong governance<br />

continued<br />

Appointments and incentives<br />

One of the Board’s main objectives is <strong>to</strong><br />

ensure management continuity. During the<br />

reporting year, a number of key managers<br />

were appointed.<br />

In 2015 a new organizational and<br />

management structure for the Group was<br />

approved. The Group's structure includes<br />

key positions that significantly influence its<br />

business. The Group’s senior managers<br />

are each responsible for the organization<br />

and development of key functions, both<br />

at the corporate level and as managers<br />

of major strategic projects. Regulation of<br />

appointments <strong>to</strong> such positions is subject <strong>to</strong><br />

rigorous control. In 2015, the Board approved<br />

the appointment of the Group’s General<br />

Counsel as Chief Compliance Officer<br />

and oversaw appointments.<br />

The Board paid particular attention<br />

<strong>to</strong> the development of remuneration and<br />

compensation principles for the Group’s<br />

key personnel. The existing compensation<br />

system was established with due regard <strong>to</strong><br />

best global remuneration practices and is<br />

aimed at achieving the Company’s annual<br />

and long-term goals. Local legislative<br />

requirements and other benefits were also<br />

taken and international relocation packages<br />

were developed.<br />

Particular attention was also paid <strong>to</strong> the<br />

process of determining and assessing<br />

annual targets.<br />

Assessment of the Board<br />

In recent years, assessment of the Board has<br />

taken the form of a questionnaire completed<br />

by Board members, followed by a discussion.<br />

In 2015, the Direc<strong>to</strong>rs were asked about the<br />

three Committees’ areas of responsibility,<br />

their satisfaction with the Board’s overall<br />

performance and which matters they<br />

deemed most essential.<br />

Matters discussed included the Company’s<br />

strategy, human resources, management<br />

tasks, corporate governance, the timely<br />

preparation of quality material, the nature<br />

of discussions at Board and Committee<br />

meetings and the Direc<strong>to</strong>rs’ satisfaction<br />

with the Board’s performance and their<br />

own contribution.<br />

Several priorities for the Board’s attention<br />

were identified:<br />

• Management structure/business<br />

process re-engineering;<br />

• Financial moni<strong>to</strong>ring;<br />

• Potash projects;<br />

• Reputation and communication<br />

management; and<br />

• Further development of IT structure and<br />

au<strong>to</strong>mation of business processes.<br />

Corporate governance<br />

In 2015 the General Meeting of Shareholders<br />

approved new versions of the Articles of<br />

Association and Regulations on the<br />

Company’s corporate governance bodies.<br />

To ensure comprehensive performance<br />

of the Board of Direc<strong>to</strong>rs as the Company’s<br />

strategic management body, Regulations<br />

on the Board’s Committees, which establish<br />

the rules regarding formation, functions and<br />

authorities of the Committees, were updated.<br />

Emphasis was made on new approaches<br />

<strong>to</strong> administer the Company’s subsidiaries<br />

<strong>to</strong> enable effective management and control<br />

over the Company’s assets. The Board<br />

updated the list of key Group companies<br />

and established procedures <strong>to</strong> prioritize<br />

and elaborate their material issues.<br />

The following decisions were made<br />

in the reporting year:<br />

• Formation of the Management Board;<br />

• Appointment of the CEO;<br />

• Formation of the Board of Direc<strong>to</strong>rs’<br />

Committees; and<br />

• Implementation of business projects and<br />

execution of transactions of essential value<br />

<strong>to</strong> the Company.<br />

Remuneration of the Board members<br />

Issues concerning Direc<strong>to</strong>rs’ remuneration<br />

are referred <strong>to</strong> the General Meeting of<br />

Shareholders. Remuneration is fixed<br />

and adjusted according <strong>to</strong> Committee<br />

memberships and Chairmanships;<br />

however, as set out in the Board Member<br />

Remuneration Regulations, only nonexecutive<br />

Direc<strong>to</strong>rs are entitled<br />

<strong>to</strong> remuneration.<br />

The <strong>to</strong>tal amount of remuneration paid<br />

<strong>to</strong> Board members for their contribution<br />

in 2015 (April <strong>to</strong> December) amounted <strong>to</strong><br />

US$1.6 million, including US$272 thousand<br />

in compensation for work-related expenses.<br />

2015<br />

US$k<br />

Total remuneration paid<br />

<strong>to</strong> the members of the Board 1,373<br />

Total compensation for<br />

work-related expenses 272<br />

Direc<strong>to</strong>rs and officers liability insurance<br />

(D&O) is provided by the Company.<br />

The Group does not have a long-term<br />

incentive program (s<strong>to</strong>ck options plan).<br />

54 EuroChem Annual Report and Accounts 2015

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!